Recruitment of the p160 coactivators by the glucocorticoid receptor: Dependence on the promoter context and cell type but not hypoxic conditions

Journal of Steroid Biochemistry and Molecular Biology

Volumn 104, Issue 3-5, 2007, Pages 305-311

  Trousson, Amalia ^a,b   Grenier, Julien ^a   Fonte, Cosima ^a   Massaad Massade, Liliane ^c   Schumacher, Michael ^a   Massaad, Charbel ^a,b  

^a Universite Paris Sud   (France)

^b CNRS   (France)

^c INSERM U612   (France)

Author keywords

Astrocytes; Coactivator; Glucocorticoid receptor; Hypoxia; p160; Schwann cells

Indexed keywords

DEFEROXAMINE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; NUCLEAR RECEPTOR COACTIVATOR 2; PROTEIN P160; SMALL INTERFERING RNA; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL HYPOXIA; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; GENETIC TRANSFECTION; GLIA CELL; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PLASMID; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHWANN CELL; SIGNAL TRANSDUCTION; TATA BOX; TRANSACTIVATION;

ANIMALS; ASTROCYTES; CELL HYPOXIA; CELLS, CULTURED; HISTONE ACETYLTRANSFERASES; NUCLEAR RECEPTOR COACTIVATOR 2; ORGAN SPECIFICITY; OXYGEN; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; SCHWANN CELLS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 34250011428     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.03.018     Document Type: Article

References (37)

1. De Nicola A.F. Steroid hormones and neuronal regeneration. Adv. Neurol. 59 (1993) 199-206
2. McEwen B.S., de Leon M.J., Lupien S.J., and Meaney M.J. Corticosteroids, the aging brain and cognition. Trends Endocrinol. Metab. 10 3 (1999) 92-96
3. Walker C., Welberg L., and Plotsky P. In: Pfaff D.W., Arnold A.P., Etgen A.M., Fahrbach S.E., and Rubin R.T. (Eds). Glucocorticoids, Stress and Development (2002), Academic Press, New York
4. Joels M., and de Kloet E.R. Effects of glucocorticoids and norepinephrine on the excitability in the hippocampus. Science 245 4925 (1989) 1502-1505
5. Meijer O.C., and de Kloet E.R. Corticosterone and serotonergic neurotransmission in the hippocampus: functional implications of central corticosteroid receptor diversity. Crit. Rev. Neurobiol. 12 1-2 (1998) 1-20
6. De Kloet E.R., Vreugdenhil E., Oitzl M.S., and Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 19 3 (1998) 269-301
7. Piazza P.V., Maccari S., Deminiere J.M., Le Moal M., Mormede P., and Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc. Natl. Acad. Sci. U.S.A. 88 6 (1991) 2088-2092
8. Pena F., and Ramirez J.M. Hypoxia-induced changes in neuronal network properties. Mol. Neurobiol. 32 3 (2005) 251-283
9. Tuor U.I. Dexamethasone and the prevention of neonatal hypoxic-ischemic brain damage. Ann. NY Acad. Sci. 765 (1995) 179-195 (discussion 196-7)
10. Tuor U.I., Manley J.J., Fyfe C., and Bascaramurty S. Dexamethasone effects on cerebral protein synthesis prior to and following hypoxia-ischemia in immature rat. Brain Res. Bull. 48 1 (1999) 61-64
11. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., et al. The nuclear receptor superfamily: the second decade. Cell 83 6 (1995) 835-839
12. Kurihara I., Shibata H., Suzuki T., Ando T., Kobayashi S., Hayashi M., Saito I., and Saruta T. Transcriptional regulation of steroid receptor coactivator-1 (SRC-1) in glucocorticoid action. Endocr. Res. 26 4 (2000) 1033-1038
13. Anzick S.L., Kononen J., Walker R.L., Azorsa D.O., Tanner M.M., Guan X.Y., Sauter G., Kallioniemi O.P., Trent J.M., and Meltzer P.S. AIB1 a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277 5328 (1997) 965-968
14. Hong H., Kohli K., Trivedi A., Johnson D.L., and Stallcup M.R. GRIP1 a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc. Natl. Acad. Sci. U.S.A. 93 10 (1996) 4948-4952
15. Suen C.S., Berrodin T.J., Mastroeni R., Cheskis B.J., Lyttle C.R., and Frail D.E. A transcriptional coactivator, steroid receptor coactivator-3, selectively augments steroid receptor transcriptional activity. J. Biol. Chem. 273 42 (1998) 27645-27653
16. Takeshita A., Cardona G.R., Koibuchi N., Suen C.S., and Chin W.W. TRAM-1 a novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1. J. Biol. Chem. 272 44 (1997) 27629-27634
17. Torchia J., Rose D.W., Inostroza J., Kamei Y., Westin S., Glass C.K., and Rosenfeld M.G. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387 6634 (1997) 677-684
18. Voegel J.J., Heine M.J., Zechel C., Chambon P., and Gronemeyer H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. Embo J. 15 14 (1996) 3667-3675
19. Grenier J., Trousson A., Chauchereau A., Amazit L., Lamirand A., Leclerc P., Guiochon-Mantel A., Schumacher M., and Massaad C. Selective recruitment of p160 coactivators on glucocorticoid-regulated promoters in Schwann cells. Mol. Endocrinol. 18 12 (2004) 2866-2879 (Epub 2004 August 26)
20. Grenier J., Trousson A., Chauchereau A., Cartaud J., Schumacher M., and Massaad C. Differential recruitment of p160 coactivators by glucocorticoid receptor between Schwann cells and astrocytes. Mol. Endocrinol. 20 2 (2006) 254-267 (Epub 2005 September 22)
21. Grenier J., Tomkiewicz C., Trousson A., Rajkowski K.M., Schumacher M., and Massaad C. Identification by microarray analysis of aspartate aminotransferase and glutamine synthetase as glucocorticoid target genes in a mouse Schwann cell line. J. Steroid Biochem. Mol. Biol. 97 4 (2005) 342-352 (Epub 2005 September 22)
22. Xu J., and Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol. Endocrinol. 17 9 (2003) 1681-1692 (Epub 2003 June 12)
23. Apostolakis E.M., Ramamurphy M., Zhou D., Onate S., and O'Malley B.W. Acute disruption of select steroid receptor coactivators prevents reproductive behavior in rats and unmasks genetic adaptation in knockout mice. Mol. Endocrinol. 16 7 (2002) 1511-1523
24. Monks D.A., Xu J., O'Malley B.W., and Jordan C.L. Steroid receptor coactivator-1 is not required for androgen-mediated sexual differentiation of spinal motoneurons. Neuroendocrinology 78 1 (2003) 45-51
25. Barkhem T., Haldosen L.A., Gustafsson J.A., and Nilsson S. Transcriptional synergism on the pS2 gene promoter between a p160 coactivator and estrogen receptor-alpha depends on the coactivator subtype, the type of estrogen response element, and the promoter context. Mol. Endocrinol. 16 11 (2002) 2571-2581
26. Leonard M.O., Godson C., Brady H.R., and Taylor C.T. Potentiation of glucocorticoid activity in hypoxia through induction of the glucocorticoid receptor. J. Immunol. 174 4 (2005) 2250-2257
27. Kodama T., Shimizu N., Yoshikawa N., Makino Y., Ouchida R., Okamoto K., Hisada T., Nakamura H., Morimoto C., and Tanaka H. Role of the glucocorticoid receptor for regulation of hypoxia-dependent gene expression. J. Biol. Chem. 278 35 (2003) 33384-33391 (Epub 2003 June 16)
28. Dardzinski B.J., Smith S.L., Towfighi J., Williams G.D., Vannucci R.C., and Smith M.B. Increased plasma beta-hydroxybutyrate, preserved cerebral energy metabolism, and amelioration of brain damage during neonatal hypoxia ischemia with dexamethasone pretreatment. Pediatr. Res. 48 2 (2000) 248-255
29. Liu Y., Wada H., Takada S., Uetani Y., Itoh H., and Nakamura H. Preventive effects of dexamethasone on hypoxic-ischemic brain damage in the neonatal rat. Brain Dev. 17 3 (1995) 186-192
30. Felszeghy K., Banisadr G., Rostene W., Nyakas C., and Haour F. Dexamethasone downregulates chemokine receptor CXCR4 and exerts neuroprotection against hypoxia/ischemia-induced brain injury in neonatal rats. Neuroimmunomodulation 11 6 (2004) 404-413
31. Paschen W., and Djuricic B. Comparison of in vitro ischemia-induced disturbances in energy metabolism and protein synthesis in the hippocampus of rats and gerbils. J. Neurochem. 65 4 (1995) 1692-1697
32. Marrif H., and Juurlink B.H. Astrocytes respond to hypoxia by increasing glycolytic capacity. J. Neurosci. Res. 57 2 (1999) 255-260
33. Tian G.F., and Baker A.J. Glycolysis prevents anoxia-induced synaptic transmission damage in rat hippocampal slices. J. Neurophysiol. 83 4 (2000) 1830-1839
34. Schurr A., West C.A., Reid K.H., Tseng M.T., Reiss S.J., and Rigor B.M. Increased glucose improves recovery of neuronal function after cerebral hypoxia in vitro. Brain Res. 421 1-2 (1987) 135-139
35. Arjona A., Mata M., Bartolome M.T., and Pascual M.L. Wallenberg syndrome secondary to cardiac catheterization. Neurologia 13 1 (1998) 59-60
36. Haberg A., Qu H., Saether O., Unsgard G., Haraldseth O., and Sonnewald U. Differences in neurotransmitter synthesis and intermediary metabolism between glutamatergic and GABAergic neurons during 4 h of middle cerebral artery occlusion in the rat: the role of astrocytes in neuronal survival. J. Cereb. Blood Flow Metab. 21 12 (2001) 1451-1463
37. Courtin F., Chantoux F., Pierre M., and Francon J. Induction of type II 5′-deiodinase activity by cyclic adenosine 3′,5′-monophosphate in cultured rat astroglial cells. Endocrinology 123 3 (1988) 1577-1581